Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis - Wikidata - awgldk - TriplyDB

Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis

Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis

http://www.wikidata.org/entity/Q37022001

about

Gene expression profiling offers insights into the role of innate immune signaling in SSc Recent advances in the genetics of systemic sclerosis: toward biological and clinical significance Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis Molecular stratification and precision medicine in systemic sclerosis from genomic and proteomic data.Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target.Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature High Rhodotorula sequences in skin transcriptome of patients with diffuse systemic sclerosis.Systems level analysis of systemic sclerosis shows a network of immune and profibrotic pathways connected with genetic polymorphisms.Experimentally-derived fibroblast gene signatures identify molecular pathways associated with distinct subsets of systemic sclerosis patients in three independent cohorts.Sustained β-catenin activity in dermal fibroblasts promotes fibrosis by up-regulating expression of extracellular matrix protein-coding genes.Multiplex cytokine analysis of dermal interstitial blister fluid defines local disease mechanisms in systemic sclerosis FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling.Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures The Histone Deacetylase Sirtuin 1 Is Reduced in Systemic Sclerosis and Abrogates Fibrotic Responses by Targeting Transforming Growth Factor β Signaling.Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial Editorial: Scleroderma: Bringing a Disease From Black-and-White Into Technicolor Skin gene expression correlates of severity of interstitial lung disease in systemic sclerosis.Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity.A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis.Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development.Personalized medicine in systemic sclerosis: facts and promises.Biomarkers in Scleroderma: Progressing from Association to Clinical Utility.Clinical Trial Design Issues in Systemic Sclerosis: an Update.Systematic approach to understanding the pathogenesis of systemic sclerosis.Identification of Optimal Mouse Models of Systemic Sclerosis by Interspecies Comparative Genomics.Connective tissue diseases: systemic sclerosis: beyond limited and diffuse subsets?Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease.Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis.Identification of novel systemic sclerosis biomarkers employing aptamer proteomic analysis.Endogenous ligands of TLR4 promote unresolving tissue fibrosis: Implications for systemic sclerosis and its targeted therapy.Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial.Thinking BIG rheumatology: how to make functional genomics data work for you.A modified murine model of systemic sclerosis: bleomycin given by pump infusion induced skin and pulmonary inflammation and fibrosis.The mechanistic implications of gene expression studies in SSc: Insights from Systems Biology Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis

P2860

Q28083733-81D020AA-C539-4A1D-88F0-BC08D7265386 Q28088499-832A72C9-446E-43DD-AE24-6C7D4C99F59B Q30845649-D99C5BE7-7031-4D51-9216-F1CB181843AE Q31020939-991FFA79-9D97-4FED-94CA-CF68C6093BBC Q33860888-273CFDF0-93C2-4CFE-B631-FB306D63796E Q33868785-74386DE2-A9B1-493A-B40E-F2ADC66ACF65 Q33916720-27AF75C1-C7E9-4C0F-9CDE-B236F5931A84 Q34888501-44074D0B-969D-4394-B9E7-54DF372A0D8F Q34995163-7A6DF564-8FF8-4CE9-8CA0-DDA205CDA7A4 Q35171136-1F2059AE-5E6D-48E8-8605-C98122E4D2A6 Q35545185-21AD805B-C3F7-483E-942A-3575B51626FA Q35551588-86ED7673-95EB-41A6-B870-8BE83157B679 Q35804073-5D3EFD38-7ECF-433D-9EA7-86DD11D9A770 Q35899075-E1EFDA87-A0A7-4B9D-9FB0-8C05A46F0899 Q35899944-EF3F6DE3-C572-4865-B0ED-64AB641F57BA Q35961706-5DA0355A-BAF6-4C0F-81E0-0FC2A46B711D Q36591571-0634B527-0C06-40B0-B34B-B57491414050 Q37503878-419B46AC-C408-499E-88CE-8788E175EF06 Q37509808-0F6566D4-5E89-481C-BAFD-9444F123F9A2 Q37717578-0041DCB2-289D-4640-B1B8-D6DCF6440A94 Q38156227-DBB99F1D-9709-4B9E-BE77-E4FF7E5B0D6C Q38206152-FEB8F80A-61AD-4785-9FDF-E2B9C49462E9 Q38771824-EA9DE162-AE87-4772-BE44-125DC29386D0 Q38825869-05B98629-743D-4C34-B10C-2731B12D3E7F Q39029340-6EB65442-A896-481C-98EE-04E00A75E5AF Q39945922-FF173C70-3A9D-4E6D-AD7C-D12BC87E70EF Q42065918-C8D666D2-F868-41E5-84D5-741DB22DFD01 Q45975840-70DE800B-7A92-402D-A917-0938C8E93B7F Q47252515-645F93AE-5525-4D05-AAA5-AF7E8026D6E4 Q47400242-3A69B43C-7402-4969-BECE-C2B4E9ED365B Q47753846-1174710A-D933-4E7D-95EE-75BEE9A7639D Q48121915-123FCABB-8195-4BE9-8E92-F0B8B6A2D0E6 Q49511487-0EB275ED-6607-442D-ABA9-98F8E711FBA6 Q52993153-28E98BD3-FD2B-4142-B095-AAC939208793 Q56763247-BFCED63B-C98E-4983-A809-F092DEA0A837 Q58572584-A692F7CF-1B9F-44AA-9006-66D0BEC13044

P2860

Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis

http://www.wikidata.org/entity/Q37022001

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 March 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Molecular signatures in skin a ...... reatment in systemic sclerosis

@en

Molecular signatures in skin a ...... eatment in systemic sclerosis.

@nl

type

label

Molecular signatures in skin a ...... reatment in systemic sclerosis

@en

Molecular signatures in skin a ...... eatment in systemic sclerosis.

@nl

prefLabel

Molecular signatures in skin a ...... reatment in systemic sclerosis

@en

Molecular signatures in skin a ...... eatment in systemic sclerosis.

@nl

P1433

Q37022001-0A4EC5BC-AE51-445D-9A7A-889CF27ABB83

P1476

Q37022001-C4D45EF3-3CE6-4855-93D8-9DF0BF4E2032

P2093

Q37022001-09F07EA7-1895-4EB6-9C22-18CA1D8F1496

Q37022001-0CF0ECE5-EF88-4EEA-A2F5-B1C31B897DC1

Q37022001-223426D8-5C31-45C2-B6CB-EECBEBB3FA3C

Q37022001-387B95F5-8A9A-480F-8DFD-470F3D16FB1E

Q37022001-4C5267C5-DF66-4FE6-88C5-5267E0239065

Q37022001-573056F5-8CDD-4F62-8A71-60333576E1BC

Q37022001-633DB831-BCA5-4A1A-9640-B5ADDB63F98D

Q37022001-867E3368-59B1-492C-952F-96F37191CBBF

Q37022001-974A09EC-C2BD-48C9-B76A-ABE1177500E5

Q37022001-A09E46A5-6B3B-4D61-982E-034E859BBAEB

P2860

Q37022001-00E6D907-A64D-4FE6-81FA-C1E52D8524D2

Q37022001-0C7FF9CE-7039-44A6-B574-843FD28D7421

Q37022001-0F9D5288-23E9-4D8D-9B3E-D35D2D24A1B6

Q37022001-1032624F-35BB-42CF-ABFC-9F60CFA89937

Q37022001-118CAE5E-485A-4A91-8FD1-9A2282CA37AF

Q37022001-18F35AA7-D673-44D8-A8EC-FEE0D589ABCC

Q37022001-2923C26C-877D-4DDF-8FCA-098134FFD812

Q37022001-2FCDFDA4-6241-4995-8BDD-F379B6C58ED0

Q37022001-3DADDCB6-52C2-4E99-8237-A3E54AA52B25

Q37022001-492AEA96-E8CE-44FB-B01D-810B611EEF17

P2888

Q37022001-84CDAC3A-E1B3-45C6-9B5E-97320C4108CA

P304

Q37022001-A90546FA-829C-456F-A9C7-789EE540D036

P31

Q37022001-4F0FD16B-4D0D-4D0E-9E9E-E3B324EDDB8F

P356

Q37022001-A38E5DEC-43B6-4991-AD56-3DEAA3DFAF52

P407

Q37022001-512717AF-4A8F-4FE4-BC0C-F17C90EF93A5

P433

Q37022001-BD6E278E-E1CB-415A-B722-D5A04BE8A893

P478

Q37022001-CD650D62-CAD5-4491-B1F8-8AF1C905ED6A

P577

Q37022001-B08AB4B1-80AA-4453-8EAD-A19E5E15DED2

P5875

Q37022001-5509FB26-B3B9-4600-B7D5-94BA909B4A12

P6179

Q37022001-46078E75-1C72-4B00-B7FF-EDC98DA9DFEB

P698

Q37022001-A56F335E-66E5-4336-A191-9013A3F0C51E

P932

Q37022001-77FC7B62-E31E-4F33-AA0B-9C238047F857

P356

P1433

Journal of Investigative Dermatology

P1476

Molecular signatures in skin a ...... reatment in systemic sclerosis

@en

P2093

Arlene Sirajuddin

http://www.w3.org/2001/XMLSchema#string

Chiang-Ching Huang

http://www.w3.org/2001/XMLSchema#string

J Matthew Mahoney

http://www.w3.org/2001/XMLSchema#string

John Varga

http://www.w3.org/2001/XMLSchema#string

Jungwha Lee

http://www.w3.org/2001/XMLSchema#string

Mary Carns

http://www.w3.org/2001/XMLSchema#string

Michael L Whitfield

http://www.w3.org/2001/XMLSchema#string

Monique Hinchcliff

http://www.w3.org/2001/XMLSchema#string

Robert Lafyatis

http://www.w3.org/2001/XMLSchema#string

Rowland W Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Statistical significance for genomewide studies

DAVID: Database for Annotation, Visualization, and Integrated Discovery

Identification of genes periodically expressed in the human cell cycle and their expression in tumors

Molecular subsets in the gene expression signatures of scleroderma skin.

Imaging lung disease in systemic sclerosis.

Egr-1 induces a profibrotic injury/repair gene program associated with systemic sclerosis.

Mechanism of action of mycophenolate mofetil.

g:Profiler--a web server for functional interpretation of gene lists (2011 update).

Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study

Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targets

P2888

P304

1979-1989

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JID.2013.130

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

133

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236911889

http://www.w3.org/2001/XMLSchema#string

P6179

1052111577

http://www.w3.org/2001/XMLSchema#string

P698

23677167

http://www.w3.org/2001/XMLSchema#string

P932

3714324

http://www.w3.org/2001/XMLSchema#string